CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Goldline Pharmaceutical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Goldline Pharmaceutical Ltd
Phone: +91 7122786666p:+91 7122786666 NAGPUR, 440015  India Ticker: 544759544759
Business Summary
Goldline Pharmaceutical Limited is an India-based company, which is engaged in the business of marketing pharmaceutical products under the brand name Goldline. The Company's product portfolio is organized into five segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Wellness. Goldline Pharma products cater to specialties such as physicians, orthopedics, ENT, chest physicians, general and specialty surgery, gastroenterology, neurology, and urology. Goldline Cardinal products serve medical fields such as physicians, diabetologists, endocrinologists, cardiologists, and general physicians. Goldline Aayushman products cater to medical fields such as pediatricians, child specialists, neonatologists, and general practitioners. Goldline InLife products serve intensivists, critical care consultants, super specialty surgeons, and physicians. Goldline Wellness is a specialized range of products for cancer survivors.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20253/31/2025-----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Managing Director Amol L.Mujumdar 54 11/10/2024 9/23/2013
Chief Financial Officer Dipti S.Bhusari 40 12/30/2024 12/30/2024
Company Secretary, Compliance Officer Ruchi S.Modi 33 10/17/2024 10/17/2024
7 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 9,600,000 (As of 5/19/2026)
Stock Exchange: BOM


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, May 29, 2026